- Home
- SION vs GAIN Comparison
SION vs GAIN Comparison
Compare SION & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SION
- GAIN
- Stock Information
- Founded
- SION 2019
- GAIN 2005
- Country
- SION United States
- GAIN United States
- Employees
- SION N/A
- GAIN N/A
- Industry
- SION
- GAIN Finance: Consumer Services
- Sector
- SION
- GAIN Finance
- Exchange
- SION NYSE
- GAIN Nasdaq
- Market Cap
- SION 583.9M
- GAIN 497.3M
- IPO Year
- SION 2025
- GAIN 2005
- Fundamental
- Price
- SION $17.10
- GAIN $13.08
- Analyst Decision
- SION Strong Buy
- GAIN Hold
- Analyst Count
- SION 1
- GAIN 2
- Target Price
- SION $32.00
- GAIN $13.75
- AVG Volume (30 Days)
- SION 202.1K
- GAIN 120.2K
- Earning Date
- SION 01-01-0001
- GAIN 05-07-2025
- Dividend Yield
- SION N/A
- GAIN 7.33%
- EPS Growth
- SION N/A
- GAIN N/A
- EPS
- SION N/A
- GAIN 1.92
- Revenue
- SION N/A
- GAIN $89,176,000.00
- Revenue This Year
- SION N/A
- GAIN $5.92
- Revenue Next Year
- SION N/A
- GAIN $10.25
- P/E Ratio
- SION N/A
- GAIN $6.83
- Revenue Growth
- SION N/A
- GAIN 6.78
- 52 Week Low
- SION $13.21
- GAIN $12.46
- 52 Week High
- SION $25.19
- GAIN $14.85
- Technical
- Relative Strength Index (RSI)
- SION N/A
- GAIN 39.87
- Support Level
- SION N/A
- GAIN $13.06
- Resistance Level
- SION N/A
- GAIN $13.59
- Average True Range (ATR)
- SION 0.00
- GAIN 0.26
- MACD
- SION 0.00
- GAIN -0.07
- Stochastic Oscillator
- SION 0.00
- GAIN 2.11
About SION SIONNA THERAPEUTICS INC
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which Heads to insufficient CFTR function.
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to (i) achieve and grow current income by investing in debt securities of established businesses. (ii) provide our stockholders with long-term capital appreciation in the value of our assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.